Rakai Health Sciences Program, Kalisizo, Uganda
Rakai Health Sciences Program, Kalisizo, Uganda.
BMJ Open. 2022 Apr 7;12(4):e050436. doi: 10.1136/bmjopen-2021-050436.
To investigate hepatitis B virus (HBV) prevalence and factors associated with viral acquisition in a HIV-hyperendemic fishing community, we tested sera for anti-hepatitis B core (HBc) and hepatitis B surface antigen (HBsAg).
Observational cross-sectional study.
Large fishing village on Lake Victoria, one of the HIV-hyperendemic Rakai Community Cohort Study (RCCS) sites (HIV prevalence ~40%).
Sample of 460 RCCS participants aged 15-49 years from survey conducted from 5 December 2016 to 13 February 2017. These proportionately included HIV-negative, HIV-positive antiretroviral therapy (ART)-naïve and HIV positive on ART participants.
Of the 460 participants, 49.6% (95% CI 45.0% to 54.1%) had evidence of prior HBV infection and 3.7% (95% CI 2.3% to 5.9%) were either acutely or chronically infected. HBV risk increased with age, number of lifetime sex partners and HIV seropositivity. HBV risk decreased with HIV ART use among HIV-positive participants. Prevalence of prior HBV infection was 17.1% in participants aged 15-19 years, 43.2%, 55.3% and 70.1% in participants aged 20-39, 30-39 and 40-49 years, respectively (p<0.001). Additionally, the prevalence of prior HBV infection was 23.8% in participants with 0-1 lifetime sex partners, 43.2% and 54.8% in participants with 2-3 lifetime sex partners and 4+ lifetime sex partners, respectively (p<0.001).
Findings from this fishing community suggest the need to provide HBV vaccination to adults at risk of sexual transmission who have not been previously immunised.
为了调查乙型肝炎病毒(HBV)在一个 HIV 高发的渔业社区的流行情况以及与病毒获得相关的因素,我们检测了血清中的乙型肝炎核心抗体(HBc)和乙型肝炎表面抗原(HBsAg)。
观察性横断面研究。
维多利亚湖的一个大型渔村,这是 Rakai 社区队列研究(RCCS)的一个 HIV 高发地点之一(HIV 流行率约为 40%)。
2016 年 12 月 5 日至 2017 年 2 月 13 日期间进行的调查中,来自 RCCS 的 460 名年龄在 15-49 岁的参与者。这些参与者按比例包括 HIV 阴性、HIV 阳性且未接受抗逆转录病毒治疗(ART)和 HIV 阳性且正在接受 ART 的参与者。
在 460 名参与者中,49.6%(95%置信区间 45.0%至 54.1%)有既往 HBV 感染的证据,3.7%(95%置信区间 2.3%至 5.9%)为急性或慢性感染。HBV 风险随着年龄、性伴侣数量和 HIV 血清阳性而增加。在 HIV 阳性参与者中,使用 HIV ART 会降低 HBV 风险。在年龄为 15-19 岁的参与者中,既往 HBV 感染的患病率为 17.1%,在年龄为 20-39 岁、30-39 岁和 40-49 岁的参与者中,分别为 43.2%、55.3%和 70.1%(p<0.001)。此外,在性伴侣数量为 0-1 的参与者中,既往 HBV 感染的患病率为 23.8%,在性伴侣数量为 2-3 和 4+的参与者中,分别为 43.2%和 54.8%(p<0.001)。
来自这个渔村的研究结果表明,需要为有性传播风险且以前未免疫的成年人提供 HBV 疫苗接种。